Results 341 to 350 of about 2,650,139 (381)
Smoothed particle hydrodynamics based FSI simulation of the native and mechanical heart valves in a patient-specific aortic model. [PDF]
Laha S, Fourtakas G, Das PK, Keshmiri A.
europepmc +1 more source
Biomimetic proteoglycans as a tool to engineer the structure and mechanics of porcine bioprosthetic heart valves. [PDF]
Petrovic M+3 more
europepmc +1 more source
Comparison of two self-expanding transcatheter heart valves for degenerated surgical bioprostheses: the AVENGER multicentre registry. [PDF]
Kim WK+47 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Medical Device Technologies, 2021
Publisher Summary A prosthetic heart valve is a medical device that replaces a diseased native valve and that enables blood flow in the cardiac chambers to be regulated. A mechanical valve consists of an occluder, an occluder retention mechanism, and a sewing cuff. A typical tissue valve consists of porcine or bovine tissue, a stent, and a sewing cuff.
Gail Baura
semanticscholar +3 more sources
Publisher Summary A prosthetic heart valve is a medical device that replaces a diseased native valve and that enables blood flow in the cardiac chambers to be regulated. A mechanical valve consists of an occluder, an occluder retention mechanism, and a sewing cuff. A typical tissue valve consists of porcine or bovine tissue, a stent, and a sewing cuff.
Gail Baura
semanticscholar +3 more sources
ACS Applied Materials and Interfaces, 2020
In recent years, valvular heart disease has become a serious disease threatening human life and is a major cause of death worldwide. However, the glutaraldehyde (GLU)-treated biological heart valves (BHVs) fail to meet all requirements of clinical ...
Chengxin Hu, Rifang Luo, Yunbing Wang
semanticscholar +1 more source
In recent years, valvular heart disease has become a serious disease threatening human life and is a major cause of death worldwide. However, the glutaraldehyde (GLU)-treated biological heart valves (BHVs) fail to meet all requirements of clinical ...
Chengxin Hu, Rifang Luo, Yunbing Wang
semanticscholar +1 more source
Biomedizinische Technik/Biomedical Engineering, 2013
Cardiac valvular pathologies are often caused by rheumatic fever in young adults, atherosclerosis in elderly patients, or by congenital malformation of the heart in children, in effect affecting almost all population ages. Almost 300,000 heart valve operations are performed worldwide annually.
Anatol Ciubotaru+5 more
openaire +3 more sources
Cardiac valvular pathologies are often caused by rheumatic fever in young adults, atherosclerosis in elderly patients, or by congenital malformation of the heart in children, in effect affecting almost all population ages. Almost 300,000 heart valve operations are performed worldwide annually.
Anatol Ciubotaru+5 more
openaire +3 more sources
Scottish Medical Journal, 1987
A patient having had both aortic and mitral valves replaced complained of triggering shop security alarms, attributing the problem to the prosthetic valves. It was demonstrated that the valves were not the cause of the problem and the source identified.
Elliott At, Bain Wh
openaire +3 more sources
A patient having had both aortic and mitral valves replaced complained of triggering shop security alarms, attributing the problem to the prosthetic valves. It was demonstrated that the valves were not the cause of the problem and the source identified.
Elliott At, Bain Wh
openaire +3 more sources
This overview of heart valve prostheses is based on a current review of clinical reports and focuses on the major complications that characterize long-term valve performance: thromboembolism, thrombosis, anti-coagulant-related bleeding, and structural failure.
Shahbudin H. Rahimtoola+1 more
openaire +2 more sources
Patents and Heart Valve Surgery – III: Percutaneous Heart Valves
Recent Patents on Cardiovascular Drug Discovery, 2014Advancements in technology for the treatment of valvularcardiac diseases seek to provide solutions for high risk patients in the form of percutaneous valve insertion for patients with complicated valvular disease not amenable to more traditional options.
F.H. Cheema+5 more
openaire +4 more sources